March 5 (Reuters) -

Consumer health company Kenvue ( KVUE ) said on Wednesday it

had appointed three new directors to its board as part of an

agreement with activist investor Starboard Value.

Kenvue ( KVUE ) has been criticized by the hedge fund for the

lackluster performance at its skin health and beauty segment,

which houses brands such as Neutrogena and Aveeno.

Starboard had last month nominated four directors to

Kenvue's ( KVUE ) board, including its CEO Jeffrey Smith.

As part of the settlement, Starboard will withdraw its

slate of nominated director candidates, Kenvue ( KVUE ) said on

Wednesday.

Kenvue ( KVUE ) said Smith has joined the board along with two

independent directors - Sarah Hofstetter, president of

e-commerce company Profitero, and Erica Mann, former head of

Bayer's consumer health unit.